Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 934 results for "aurobindo"

Aurobindo gets USFDA approval for anti-infection drug
Business Standard

Aurobindo: Long-term benefits outweigh near-term challenges

The share price of Hyderabad-based Aurobindo Pharma has zoomed from Rs 180 levels in September last year to its all-time high of Rs 908 last week, largely led by strong business growth in the international markets. After getting a nod from the ... Business Standard India, 14 minutes ago
DRL, Aurobindo Dragged to US Court Over Patents New Indian Express, 8 hours ago
Stocks to watch out on Monday, 3 days ago

11 images for aurobindo

Business Standard India, 2 days ago, 2 days ago
Bangladesh Daily Star, 2 weeks ago
India Education, 3 weeks ago, 1 month ago
Bio Spectrum Asia, 1 month ago, 2 months ago, 2 months ago, 2 months ago
The Hindu, 2 months ago

Reckitt files patent infringement case against Aurobindo Pharma

Summary New Jersey-based Reckitt Benckiser LLC has filed a patent infringement case against Aurobindo Pharma. New Jersey-based Reckitt Benckiser LLC has filed a patent infringement case against Aurobindo Pharma. The infringement ...
 Financial Express10 hours ago INDIA PRESS-Reckitt files patent infringement case against Aurobindo Pharma - Financial Express  Reuters UK4 hours ago

Bull's Eye: Buy Biocon, India Cements, Aurobindo Pharma

Vishal Malkan, advises buying India Cements for a target price of Rs 138 and Aurobindo Pharma for a target price of Rs 900.
 Money Control1 day ago Bull's Eye: JP Associates, Tech Mahindra, Aurobindo Pharma  Money Control4 weeks ago Buy LIC Housing, Tata Comm, Aurobindo Pharma: Manav Chopra  Money Control1 month ago Bull's Eye: Buy Aurobindo, Adani Enterprises; short IFCI  Money Control1 month ago

Think now | Sri Aurobindo

The Unknown is not the Unknowable; it need not remain the unknown for us, unless we choose ignorance or persist in our first limitations. For to all things that are not unknowable, all things in the universe, there correspond in that universe ...
 New Delhi Pioneer1 day ago

Buy Aurobindo Pharma, says Sudarshan Sukhani

Sudarshan Sukhani of recommends buying Aurobindo Pharma.
 Money Control4 days ago Stocks in news: Aurobindo, Maruti, Bhushan, Apollo Tyres  Money Control6 days ago Aurobindo Pharma may test Rs 865-870: Sudarshan Sukhani  Money Control2 weeks ago Buy Aurobindo Pharma, BPCL, Maruti Suzuki: Sukhani  Money Control1 month ago

Vanguard Group buys 23.60 lakh Aurobindo Pharma shares

Aurobindo Pharma shares were purchased for an average price of Rs 875.94 apiece, amounting the transaction to Rs 206.74 crore. The drug firm became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being a ...
 Money Today3 days ago Vanguard Group buys Aurobindo Pharma shares worth Rs 206.74 cr  Business Standard3 days ago

Rabindra-Nazrul evening

A unique musical programme named as "Rabindra - Nazrul Sandhya" was performed atShri Aurobindo Bhavan on September 14 by music teachers and their students of Port Blair and nearby areas. It was a memorable program by
 The Echo Of India6 days ago Rabindra-Nazrul Sandhya today  The Echo Of India1 week ago

Stocks in news: Hero Moto, Aurobindo, JSW Steel

Quotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges . Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page . Quotes are updated ...
 Yahoo! India5 days ago
Business Standard India

Health care companies' scrips canter along

So far this year, the defensive sector stocks have risen by about 38 per cent. Aurobindo Pharma, Ranbaxy Labs, Cipla and Lupin are among the top performers, where prices have risen over 50 per cent since the beginning of this financial year.
 Business Standard India1 week ago

Buy Aurobindo Pharma with a target of Rs 884: Ashwani Gujral

In a chat with ET Now, Ashwani Gujral, Fund Manager,, shares his views on Aurobindo Pharma. ET Now: What is your call on Aurobindo Pharma? Ashwani Gujral: Aurobindo Pharma is a 'BUY' call with a target of Rs 884 and a stop loss of ...
 Economic Times2 weeks ago Super Six stocks that should do well today  Money Control2 weeks ago Buy Aurobindo Pharma, FDC, Kaveri Seed: Paras Bothra  Money Control3 weeks ago Aurobindo Pharma may hit Rs 880-890: Ashish Chaturmohta  Money Control3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less